ArticleJournal of pharmaceutical analysis2026
Arctigenin discovered by high-throughput screening ameliorates doxorubicin-induced cardiotoxicity as a novel natural KEAP1-NRF2 inhibitor.
Xinyu Heng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.